All Type of News
Health insurance coverage plans to be proposed for chemically modified medicines
The Ministry of Health, Welfare and Family Affairs plans to hold a public hearing in the middle of this month over its insurance coverage plans for chemically modified drugs.
According to the ministry plan, newly s...
KFDA makes public new GMP rules
The Korea Food and Drug Administration announced on April 1 it has established a new GMP rules aiming to promote new good manufacturing practice and validation in more enterprise-friendly manner.
According to the r...
Multinationals abuse Korea's patent trial system
Pfizer Korea and Sanofi-Aventis Korea have sought to prevent the insurance prices of their original medicine from being decreased by 20 percent, when a generic drug gets listed for insurance coverage, through a trial ...
Business lobby group calls for reforming pharmaceutical administration rules
Korea should revise regulations in the domestic pharmaceutical sector, said the Korea Pharmaceutical Industry Cooperative.
In a recent filing with the Regulatory Reform Committee, the cooperative said it is necessa...
Wholesalers wary of margin reduction
Drug wholesalers are closely watching pharmaceutical firms' movement to see if the current wholesaler margin is falling.
Wholesalers are watching pharmaceutical company's attempts to lower the margin, which will af...
KFDA to back generic drugs development
The Korea Food and Drug Administration says it plans to work out measures aimed at encouraging pharmaceutical firms to develop more effective and cheaper drugs, strengthening the competitiveness of the country's pharm...
Dispute rekindling over GSK margin issue
Tension has been escalating over the wholesaler margin issue of GlaxoSmithKline, who slashed its associate wholesaler margin by 1.5 percent last December.
In a meeting on April 31, the Pharmaceutical Development Co...
90% of pharmacies install DUR soft ware
90 percent of pharmacies have completed installing the drug utilization review (DUR) software, such as Pharm Manager 2000 or 앳팜, to cope with the government's compulsory DUR program.
Under the plan, all medical ins...
Dongwha teams up with Teijin over DW1350
Dongwha Pharm says on April 1 that it entered into a technology transfer agreement with Teijin Pharma under which Teijin will have exclusive rights to develop and commercialize a novel class of molecules for the treat...
New anti-hyperlipidemic substance found
We discovered the new physiological functions of chlorophyll water that is extracted from a number of plants, and expect that the water may be used as an ingredient for various industries, said Yoon Yong-chul, chairma...
